Some emerging studies are showing that it may be possible for patients to taper off of weight loss drugs or take lower doses and maintain a lower BMI
Among these products, berberine, chromium, cinnamon, curcumin, and probiotics have the potential to improve glycemic control and, in some cases, to modulate GLP-1 signaling
In a retrospective analysis of 110 obese patients with type 2 diabetes treated with liraglutide, the mean concentration of CRP declined after treatment with liraglutide for a mean duration of 7.5 months [9]
I was also recently catching up with my friend and fellow pharmacist, Derek Borkowski who is the founder of pyrls.com and they again would like to share their excellent PDF on the updated treatment algorithm which you can see a preview of at the end of this post
This delayed gastric emptying is central to both the therapeutic effect and the side effect profile of these injections